Biologic Imaging Reagents Market Outlook 2024: Exclusive Report By The Business Research Company | Cardinal Health Inc., Johnson And Johnson Services Inc., Bayer Healthcare AG, Thermo Fisher Scientific Inc., Siemens Healthcare GmbH, Dickinson and Company

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2061

The Business Research Company offers in-depth market insights through Biologic Imaging Reagents Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The biologic imaging reagents market size has grown rapidly in recent years. It will grow from $16.69 billion in 2023 to $18.41 billion in 2024 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to rise in prevalence of chronic diseases, growing research and development investments, shift towards personalized medicine, focus on early disease detection, increasing geriatric population, collaborations in biomedical research..

The biologic imaging reagents market size is expected to see strong growth in the next few years. It will grow to $25.72 billion in 2028 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to expanding applications in drug development, rising demand for molecular imaging, focus on non-invasive diagnostic methods, global increase in cancer cases, shift towards value-based healthcare.. Major trends in the forecast period include rise in demand for contrast-enhanced imaging agents, development of targeted molecular imaging agents, application of nanoparticles in imaging, emergence of fluorescent probes for in vivo imaging, integration of artificial intelligence in image analysis..

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=13389&type=smp

Market Segmentation:
The main types of products in biologic imaging reagents are contrast reagents, optical imaging reagents and radiopharmaceuticals. Contrast reagents refer to substances used in medical imaging to enhance the visibility of specific tissues. It includes various modalities such as magnetic resonance imaging (MRI), ultrasound, x-ray and computerized tomography (CT), nuclear, optical and others, used in various applications, including in vitro and in vivo. These are utilized by diagnostic laboratories, imaging centers, life science companies, research and academic institutes, and others.

Major Driver - Chronic Disease Prevalence Fuels Growth of Biologic Imaging Reagents Market
The increase in the prevalence of chronic diseases is expected to propel the growth of the biologic imaging reagents market going forward. Chronic diseases refer to conditions that last one year or longer and require continuous medical attention, which may worsen over time. Chronic diseases require biologic imaging reagents to diagnose and detect diseases by visualizing organs and affected structures. For instance, in 2022, according to the American Cancer Society, a US-based voluntary organization, the number of new cancer cases and fatalities expected was estimated to be 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the United States. Furthermore, in December 2021, according to the IDF Diabetes Atlas Tenth Edition 2021 report published by the International Diabetes Federation, a Belgium-based umbrella organization of national diabetes associations, 537 million persons (20-79 years old) were estimated to have diabetes in 2021. By 2030, there will be 643 million diabetics worldwide, and by 2045, there will be 783 million. The increase in the prevalence of chronic diseases is driving the growth of the biologic imaging reagents market.

Competitive Landscape:
Major companies operating in the biologic imaging reagents market report are Cardinal Health Inc., Johnson And Johnson Services Inc., Bayer Healthcare AG, Thermo Fisher Scientific Inc., Siemens Healthcare GmbH, Dickinson and Company (BD), Koninklijke Philips N.V., GE HealthCare Technologies Inc., Stryker Corporation, FluoroPharma Medical Inc., Lonza Group AG, Illumina Inc. , PerkinElmer Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Bracco Diagnostics Inc., Leica Microsystems GmbH, Lantheus Medical Imaging Inc., Guerbet SA, Miltenyi Biotec B.V. and Co. KG, Promega Corporation, Abcam plc., Luminex Corporation, MILabs, LI-COR Biosciences, FUJIFILM VisualSonics Inc., Advanced Proteome Therapeutics Incorporated, BIOPRO Baden-Württemberg GmbH, ABX Advanced Biochemical Compounds GmbH

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/biologic-imaging-reagents-global-market-report

Top Trend - Innovative Reagents Revolutionize Biologic Imaging
Major companies operating in the biologic imaging reagents market are focusing on developing innovative reagents, such as novel dye technology, offering researchers and clinicians a new tool for visualizing and improving the sensitivity and specificity of biologic imaging. Novel dye technology refers to developing new dyes for various applications, including biological imaging. For instance, in April 2022, Becton, Dickinson, and Company, a US-based medical device company, launched BD Horizon RealYellow 586 Reagents and RealBlue Reagents. This new family of reagents allows researchers to acquire higher data resolution and more insights from samples than standard fluorochrome. It is due to employing revolutionary dye technology and artificial intelligence (AI) supervision. The AI assessed existing data from excitation and emission profiles of commercially available fluorochromes and then determined the best places in laser lines to develop novel dyes.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Biologic Imaging Reagents Market Characteristics
3. Biologic Imaging Reagents Market Trends And Strategies
4. Biologic Imaging Reagents Market - Macro Economic Scenario
5. Biologic Imaging Reagents Market Size And Growth
…..
27. Biologic Imaging Reagents Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.